The RELENT Project
The RELENT Project
The RELENT Project

Facts about RELENT

RELapses prevENTion in chronic autoimmune disease: common mechanisms and co-morbidities (RELENT, grant agreement no. 668036) is a multidisciplinary group of nine scientific partners and four SMEs from Europe, and Australia funded by the European Union’s Horizon 2020 research and innovation programme.

  • The overall aim of RELENT is to develop individualised treatments for autoimmune diseases
  • RELENT has undefined13 partners, from six European countries and one from Australia
  • Nearly 6 Million Euros in project funding provided by the European Commission (H2020)
  • RELENT is coordinated by undefinedRenate Kain from the Medical University Vienna
  • 4.5 years of funding for the project started on 1/11/2015

The RELENT Consortium

RELENT partners

Newsletter Subscription

Please fill in the information of your subscription.


You have already subscribed to Newsletter Recipients and wish to update or terminate your subscription? Click here!

News Section

The understanding of AAV pathogenesis isincreasing, leading to improvements in... Read more

Social Media